Cho NH, Shawe JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.
CAS Article PubMed Google Scholar
Holman N, Young B, Gadsby R. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med. 2015;32:1119–20. https://doi.org/10.1111/dme.12791.
CAS Article PubMed Google Scholar
Bruno G, Runzo C, Cavallo-Perin P, Merlletti F, Rivetti M, Pinach S, et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care. 2005;28:2613–9. https://doi.org/10.2337/diacare.28.11.2613.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27:269–73. https://doi.org/10.5001/omj.2012.68.
CAS Article PubMed PubMed Central Google Scholar
Giovannucci E, Harlan DM, Archer MC, Bergenstalet RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207–21. https://doi.org/10.3322/caac.20078.
Shlomai G, Neel B, LeRoith D, Gallagher EJ. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy. J Clin Oncol. 2016;34:4261–9. https://doi.org/10.1200/JCO.2016.67.4044.
CAS Article PubMed PubMed Central Google Scholar
Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK, et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother. 2018;107:306–28. https://doi.org/10.1016/j.biopha.2018.07.157.
CAS Article PubMed Google Scholar
Zhou T, Hu Z, Yang S, Sun L, Yu Z, Wang G, et al. Role of adaptive and innate immunity in type 2 diabetes mellitus. J Diabetes Res. 2018;2018:7457269. https://doi.org/10.1155/2018/7457269.
CAS Article PubMed PubMed Central Google Scholar
Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4:493–503. https://doi.org/10.2174/1389450033490966.
CAS Article PubMed Google Scholar
Dalmas E. Role of innate immune cells in metabolism: from physiology to type 2 diabetes. Semin Immunopathol. 2019;41:531–45. https://doi.org/10.1007/s00281-019-00736-5.
Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017:6494795. https://doi.org/10.1155/2017/6494795.
CAS Article PubMed PubMed Central Google Scholar
Gardiner CM. NK cell metabolism. J Leukoc Biol. 2019;105:1235–42. https://doi.org/10.1002/JLB.MR0718-260R.
CAS Article PubMed Google Scholar
Van den Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 2017;38:395–406. https://doi.org/10.1016/j.it.2017.03.001.
CAS Article PubMed Google Scholar
Nam HW, Cho YJ, Lim JA, Kim SJ, Kim H, Sim SY, et al. Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus. Clin Exp Immunol. 2018;194:125–36. https://doi.org/10.1111/cei.13187.
CAS Article PubMed PubMed Central Google Scholar
Chen Y, Tian Z. Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cell Mol Immunol. 2021;18:57–72. https://doi.org/10.1038/s41423-020-00561-z.
CAS Article PubMed Google Scholar
Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with gammadelta T cells: many paths ahead of us. Cell Mol Immunol. 2020;17:925–39. https://doi.org/10.1038/s41423-020-0504-x.
CAS Article PubMed PubMed Central Google Scholar
Foord E, Arruda LCM, Gaballa A, Klynning C, Uhlin M. Characterization of ascites- and tumor-infiltrating gammadelta T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci Transl Med. 2021;13:eabb0192. https://doi.org/10.1126/scitranslmed.abb0192.
CAS Article PubMed Google Scholar
Xiang Z, Tu W. Dual face of Vgamma9Vdelta2-T cells in tumor immunology: anti- versus pro-tumoral activities. Front Immunol. 2017;8:1041. https://doi.org/10.3389/fimmu.2017.01041.
CAS Article PubMed PubMed Central Google Scholar
Hayday AC. gammadelta T cell update: adaptate orchestrators of immune surveillance. J Immunol. 2019;203:311–20. https://doi.org/10.4049/jimmunol.1800934.
CAS Article PubMed Google Scholar
O’Brien RL, Born WK. gammadelta T cell subsets: a link between TCR and function? Semin Immunol. 2010;22:193–8. https://doi.org/10.1016/j.smim.2010.03.006.
CAS Article PubMed PubMed Central Google Scholar
Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. 2013;13:88–100. https://doi.org/10.1038/nri3384.
CAS Article PubMed PubMed Central Google Scholar
Bonneville M, O’Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10:467–78. https://doi.org/10.1038/nri2781.
CAS Article PubMed Google Scholar
Born WK, Reardon CL, O’Brien RL. The function of gammadelta T cells in innate immunity. Curr Opin Immunol. 2006;18:31–38. https://doi.org/10.1016/j.coi.2005.11.007.
CAS Article PubMed Google Scholar
Zheng J, Liu Y, Lau YL, Tu W. gammadelta-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol. 2013;10:50–57. https://doi.org/10.1038/cmi.2012.43.
CAS Article PubMed Google Scholar
Zheng J, Wu WL, Liu Y, Xiang Z, Liu M, Chan KH, et al. The therapeutic effect of pamidronate on lethal avian influenza A H7N9 virus infected humanized mice. PLoS One. 2015;10:e0135999. https://doi.org/10.1371/journal.pone.0135999.
CAS Article PubMed PubMed Central Google Scholar
Li J, Li H, Mao H, Yu M, Feng T, Yang F, et al. Vgamma9Vdelta2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates. Cell Mol Immunol. 2013;10:253–60. https://doi.org/10.1038/cmi.2012.78.
CAS Article PubMed PubMed Central Google Scholar
Pei Y, Xiang Z, Huang C, Wang X, Mu X, Wen L, et al. CD137 costimulation enhances the antiviral activity of Vgamma9Vdelta2-T cells against influenza virus. Signal Transduct Target Ther. 2020;5:74. https://doi.org/10.1038/s41392-020-0174-2.
CAS Article PubMed PubMed Central Google Scholar
Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He Y, et al. Allogeneic Vgamma9Vdelta2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cell Mol Immunol. 2021;18:427–39. https://doi.org/10.1038/s41423-020-0515-7.
CAS Article PubMed Google Scholar
Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D, et al. Innate immune functions of human gammadelta T cells. Immunobiology. 2008;213:173–82. https://doi.org/10.1016/j.imbio.2007.10.006.
CAS Article PubMed Google Scholar
Nielsen MM, Witherden DA, Havran WL. gammadelta T cells in homeostasis and host defence of epithelial barrier tissues. Nat Rev Immunol. 2017;17:733–45. https://doi.org/10.1038/nri.2017.101.
CAS Article PubMed PubMed Central Google Scholar
Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood. 2010;116:1726–33. https://doi.org/10.1182/blood-2009-07-234211.
CAS Article PubMed PubMed Central Google Scholar
Chen Q, Wen K, Lv A, Liu M, Ni K, Xiang Z, et al. Human Vgamma9Vdelta2-T cells synergize CD4(+) T follicular helper cells to produce influenza virus-specific antibody. Front Immunol. 2018;9:599. https://doi.org/10.3389/fimmu.2018.00599.
CAS Article PubMed PubMed Central Google Scholar
Silva-Santos B, Mensurado S, Coffelt SB. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer. 2019;19:392–404. https://doi.org/10.1038/s41568-019-0153-5.
CAS Article PubMed Google Scholar
Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, et al. Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease. Cancer Cell. 2014;26:565–76. https://doi.org/10.1016/j.ccr.2014.07.026.
CAS Article PubMed Google Scholar
Wang X, Xiang Z, Liu Y, Huang C, Pei Y, Wang X, et al. Exosomes derived from Vdelta2-T cells control Epstein-Barr virus-associated tumors and induce T cell antitumor immunity. Sci Transl Med. 2020;12:eaaz3426. https://doi.org/10.1126/scitranslmed.aaz3426.
留言 (0)